Skip to main content

Tana Mouse

IM MRS.MOUSEWelcome to my office!

This year is going to be a little different with this black cloud over us all but together we will make it work ! This year we all will be wearing a mask so i figured id put a picture on here pre-covid! Please if you have any questions call me 

Hello I'd like to introduce myself, My name is Tana Mouse many may recognize me as Tana Holt. I am  your new nurse for the Upper Elementary School .I would like to touch base a little on this black cloud over us all Covid-19 .So what do we look for and what is time expectancy? 

  Symptoms and Severity of COVID-19 in Children

Clinical Presentation

The incubation period of SARS-CoV-2 appears to be about the same for children as in adults, at 2-14 days with an average of 6 days.10

Signs or symptoms of COVID-19 in children include:

  • Fever

  • Fatigue

  • Headache

  • Myalgia

  • Cough

  • Nasal congestion or rhinorrhea

  • New loss of taste or smell

  • Sore throat

  • Shortness of breath or difficulty breathing

  • Abdominal pain

  • Diarrhea

  • Nausea or vomiting

  • Poor appetite or poor feeding

Children infected with SARS-CoV-2 may have many of these non-specific symptoms, may only have a few (such as only upper respiratory symptoms or only gastrointestinal symptoms), or may be asymptomatic. The most common symptoms in children are cough and/or fever.11-15 A recent systematic review estimated that 16% of children with SARS-CoV-2 infection are asymptomatic,16 but evidence suggests that as many as 45% of pediatric infections are asymptomatic.17 The signs and symptoms of COVID-19 in children are similar to other infections and noninfectious processes, including influenza, streptococcal pharyngitis, and allergic rhinitis. The lack of specificity of signs or symptoms and the significant proportion of asymptomatic infections make symptom-based screening for identification of SARS-CoV-2 in children particularly challenging.17

Severity of Illness in Children

While children infected with SARS-CoV-2 are less likely to develop severe illness compared with adults, children are still at risk of developing severe illness and complications from COVID-19. Recent COVID-19 hospitalization surveillance data shows that the rate of hospitalization among children is low (8.0 per 100,000 population) compared with that in adults (164.5 per 100,000 population), but hospitalization rates in children are increasing. 5  While children have lower rates of mechanical ventilation and death than adults, 1 in 3 children hospitalized with COVID-19 in the United States were admitted to the intensive care unit, which is the same in adults.5   

Current evidence suggests that children with certain underlying medical conditions and infants (age <1 year) might be at increased risk for severe illness from SARS-CoV-2 infection.10,11,14 Of the children who have developed severe illness from COVID-19, most have had underlying medical conditions. 5

  • There is limited evidence about which underlying medical conditions in children might increase the risk for severe illness. Current evidence suggests that children with medical complexity, with genetic, neurologic, metabolic conditions, or with congenital heart disease might be at increased risk for severe illness from COVID-19. Similar to adults, children with obesity, diabetes, asthma and chronic lung disease, sickle cell disease, or immunosuppression might also be at increased risk for severe illness from COVID-19.

  • While healthcare providers should maintain a high index of suspicion for SARS-CoV-2 infection in these populations and monitor the progression of illness closely, it appears that most infants18 and children with certain underlying conditions such as cancer19 who are infected with SARS-CoV-2 do not usually develop severe illness.

  • Hospitalization rates in the United States are higher among Hispanic/Latino children and black, non-Hispanic children and non-Hispanic black children compared with white children, which may be related to the higher rates of obesity and other underlying conditions among these populations.5

Similar to adults, children with severe COVID-19 may develop respiratory failure, myocarditis, shock, acute renal failure, coagulopathy, and multi-organ system failure. Some children with COVID-19 have developed other serious problems like intussusception or diabetic ketoacidosis.10,14, 20,21 Children infected with SARS-CoV-2 are also at risk for developing multisystem inflammatory syndrome in children (MIS-C).22 For the case definition, recommended evaluation, and current data on MIS-C cases in the United States, visit MIS-C Information for Healthcare Providers.

Testing and Recommendations for Isolation

Viral tests (nucleic acid or antigen) are recommended to diagnose acute infection with SARS-CoV-2. Testing strategies, including clinical criteria for considering testing and recommended specimen type, are the same for children and adults. CDC’s guidance for the evaluation and management of neonates at risk for COVID-19 details specific testing considerations for newborns.

For more information on CDC’s recommendations for isolation, which apply to children and adults, visit: discontinuing precautions and disposition of patients with COVID-19 in healthcare settings and discontinuation of home isolation for people not in healthcare settings.

Testing, Isolation, and Quarantine for School-Aged Children

As children return to school and other in-person activities, pediatric healthcare providers should be prepared to answer questions from families about testing and when it is safe to return to school or be with people outside the household. Review CDC’s information for school administrators on symptom screening and return to school and testing for children in school as well as CDC’s Community Mitigation framework.

School-aged children should be prioritized for viral testing if they have:

  • Signs or symptoms of COVID-19 and have had

    • close contact (within 6 feet of someone for a total of 15 minutes or more) with a person with suspected or confirmed SARS-CoV-2 infection or

    • a potential exposure (which includes living in an area or traveling to an area with in the community as defined by the local public health department  and described in CDC’s Community Mitigation framework)

  • a known recent exposure to SARS-CoV-2 regardless of symptoms.

Children with symptoms of an infectious disease should not attend school, but the length of time the child should stay home depends on the most likely etiology of illness (COVID-19 or not). Return to school policies for children with suspected or confirmed COVID-19 should be based on CDC’s recommendation for discontinuation of home isolation. A negative test or doctor’s note should not be required for return to school upon completion of the 10 days of isolation with improvement of symptoms.

  • If the child has symptoms of COVID-19 but has not had close contact or a potential exposure (which includes travel to or living in an area with substantial transmission), he or she should be evaluated for possible other disease processes and should be allowed to return to school according to existing school policies if they are determined to likely not have COVID-19. Examples of non-COVID return to school policies include resolution of fever without antipyretics for 24 hours for viral illnesses or after initiation of antibiotics for bacterial illnesses.

  • If the child has symptoms of COVID-19 and lives in or has traveled to an area with substantial transmission, he or she should be tested for SARS-CoV-2 infection, if possible. If the test result is negative, the child should be allowed to return to school once their symptoms of illness have improved consistent with existing school policy. If testing cannot be obtained, the child should be considered a presumed case of COVID-19 and should isolate according to CDC’s recommendations for discontinuation of home isolation.

  • If the child has had a known exposure or close contact to someone with SARS-CoV-2, he or she should be tested for SARS-CoV-2 but must remain in quarantine for the 14-day incubation period even if results are negative, in accordance with CDC’s Quarantine If You Might Be Sick.


  •  Please contact me if you have future questions.Upper Elementary 918-253-3535 




Tana Mouse

Upcoming Events

Contact Tana Mouse

Cell Phone: